Literature DB >> 27054513

Clinical Application of Liquid Biopsies.

P Mickey Williams1, Barbara A Conley2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27054513     DOI: 10.1001/jamaoncol.2016.0240

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer.

Authors:  Rohan Gupta; Tamer Othman; Chen Chen; Jaideep Sandhu; Ching Ouyang; Marwan Fakih
Journal:  Oncologist       Date:  2019-11-19

2.  On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood.

Authors:  H Cai; M A Stott; D Ozcelik; J W Parks; A R Hawkins; H Schmidt
Journal:  Biomicrofluidics       Date:  2016-12-15       Impact factor: 2.800

3.  Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer.

Authors:  Rohan Gupta; Tamer Othman; Chen Chen; Jaideep Sandhu; Ching Ouyang; Marwan Fakih
Journal:  Oncologist       Date:  2019-11-18

4.  Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.

Authors:  Young Kwang Chae; Andrew A Davis; Benedito A Carneiro; Sunandana Chandra; Nisha Mohindra; Aparna Kalyan; Jason Kaplan; Maria Matsangou; Sachin Pai; Ricardo Costa; Borko Jovanovic; Massimo Cristofanilli; Leonidas C Platanias; Francis J Giles
Journal:  Oncotarget       Date:  2016-10-04

5.  Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.

Authors:  Cathy Zhou; Zilong Yuan; Weijie Ma; Lihong Qi; Angelique Mahavongtrakul; Ying Li; Hong Li; Jay Gong; Reggie R Fan; Jin Li; Michael Molmen; Travis A Clark; Dean Pavlick; Garrett M Frampton; Brady Forcier; Elizabeth H Moore; David K Shelton; Matthew Cooke; Siraj M Ali; Vincent A Miller; Jeffrey P Gregg; Philip J Stephens; Tianhong Li
Journal:  J Hematol Oncol       Date:  2018-11-06       Impact factor: 17.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.